Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain. (Q50973812)

26 March 2018

title

Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain. (English)

1 reference

26 March 2018

0 references

Rubió PP

1

1 reference

26 March 2018

publication date

1 January 1997

1 reference

26 March 2018

published in

Public Health

1 reference

26 March 2018

volume

111

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

33-40

1 reference

26 March 2018

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Serum cholesterol in young men and subsequent cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Results of a two-year health education campaign on dietary behavior. The Stanford Three Community Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Strategy of prevention: lessons from cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Epidemiology of cardiovascular disease risk factors in Catalonia (Spain)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Principles of cost-effective resource allocation in health care organizations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Cholesterol reduction and life expectancy. A model incorporating multiple risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Cost-effectiveness of interventions to prevent or treat coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

The cost-effectiveness of counseling smokers to quit.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PH.1900304

7 January 2021

Identifiers

DOI

10.1038/SJ.PH.1900304

1 reference

26 March 2018

PubMed ID

9033222

1 reference

26 March 2018